肩关节置换术中肌间沟臂丛阻滞与可注射布比卡因脂质体随机对照试验
阻滞组术中阿片类消耗量更低、术后0和8小时疼痛评分更优,但术后24小时疼痛评分更高。
要点
- 术后24小时吗啡当量消耗量阻滞组14.8±11.3 vs 悬液组14.4±16.8(p=0.849),无显著差异。
- 术中阿片类消耗量阻滞组8.9±4.1 vs 悬液组16.2±7.0吗啡当量单位(p<0.001),阻滞组更低。
- 术后24小时疼痛VAS评分阻滞组4.9±2.7 vs 悬液组3.9±2.3分(p=0.021),阻滞组更高。
核心结论
- 接受布比卡因脂质体注射混悬液的患者术后阿片类需求与肌间沟臂丛阻滞组相当,但术中阿片类需求更高。
- 肌间沟臂丛阻滞在术后前8小时提供更好的疼痛评分,但术后24小时疼痛评分更差。
- 肩关节置换的最佳术后疼痛方案和镇痛技术的成本效益需进一步研究。
研究设计与样本
- 非盲随机对照试验,纳入接受初次肩关节置换的患者。
- 患者随机分配至肌间沟臂丛阻滞组或术中布比卡因脂质体注射混悬液软组织浸润组。
- 肌间沟臂丛阻滞组78例,布比卡因脂质体注射混悬液组78例。
- 主要结局为术后第一个24小时吗啡当量消耗量。
- 证据等级:治疗性II级。
主要发现
- 术后24小时平均总阿片类消耗量阻滞组14.8±11.3 vs 悬液组14.4±16.8吗啡当量单位(p=0.849)。
- 术中阿片类消耗量阻滞组8.9±4.1 vs 悬液组16.2±7.0吗啡当量单位(p<0.001),阻滞组显著更低。
- 术后0小时VAS疼痛评分阻滞组0.8±2.2 vs 悬液组3.3±2.7分(p<0.001),阻滞组显著更低。
- 术后8小时VAS疼痛评分阻滞组1.4±2.4 vs 悬液组3.2±2.2分(p<0.001),阻滞组显著更低。
- 术后16小时VAS疼痛评分阻滞组4.3±2.8 vs 悬液组3.8±2.4分(p=0.348),无显著差异;术后24小时阻滞组4.9±2.7 vs 悬液组3.9±2.3分(p=0.021),阻滞组显著更高。
临床怎么用
- 原文未据本研究结果给出临床推荐。
局限性
- 肩关节置换的最佳术后疼痛方案和镇痛技术的成本效益需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Shortcomings of interscalene brachial plexus blockade include technical failure and rebound pain. Bupivacaine liposome injectable suspension, a sustained release preparation, is used for surgical-site administration. The purpose of this study was to evaluate these 2 postoperative pain management strategies in patients undergoing shoulder arthroplasty. METHODS: In a non-blinded, randomized controlled trial of participants undergoing primary shoulder arthroplasty, patients were randomized to interscalene brachial plexus blockade or intraoperative soft-tissue infiltration of bupivacaine liposome injectable suspension. The primary outcome variable was morphine equivalent units consumed over the first 24 hours postoperatively. Secondary outcomes included morphine equivalent units consumed intraoperatively and a visual analog scale (VAS) for pain at 0, 8, 16, and 24 hours. RESULTS: Seventy-eight patients were randomized to interscalene brachial plexus blockade treatment (the blockade group) and 78 patients were randomized to bupivacaine liposome injectable suspension treatment (the suspension group). The mean total postoperative narcotic consumption (and standard deviation) over 24 hours after the surgical procedure was 14.8 ± 11.3 morphine equivalent units in the blockade group compared with 14.4 ± 16.8 morphine equivalent units in the suspension group (p = 0.849). Intraoperative narcotics were significantly lower (p < 0.001) in the blockade group (8.9 ± 4.1 morphine equivalent units) compared with the suspension group (16.2 ± 7.0 morphine equivalent units). The mean VAS pain score was significantly lower in the blockade group than in the suspension group at 0 hours postoperatively (0.8 ± 2.2 compared with 3.3 ± 2.7 points; p < 0.001) and at 8 hours postoperatively (1.4 ± 2.4 compared with 3.2 ± 2.2 points; p < 0.001), but it was not significantly different at 16 hours postoperatively (4.3 ± 2.8 compared with 3.8 ± 2.4 points; p = 0.348). The VAS pain scores were significantly higher (p = 0.021) in the blockade group (4.9 ± 2.7 points) compared with the suspension group (3.9 ± 2.3 points) at 24 hours postoperatively. CONCLUSIONS: Patients treated with bupivacaine liposome injectable suspension required an equivalent amount of postoperative narcotics and greater intraoperative narcotics compared with patients treated with interscalene brachial plexus blockade. Although interscalene brachial plexus blockade provided improved pain scores for the first 8 hours after the surgical procedure, pain scores were worse at 24 hours. The optimal postoperative pain regimen for shoulder arthroplasty and the cost-effectiveness of analgesic techniques require further investigation. LEVEL OF EVIDENCE: Therapeutic Level II. See Instructions for Authors for a complete description of levels of evidence.
引用
- Namdari S, Nicholson T, Abboud J, et al. Randomized Controlled Trial of Interscalene Block Compared with Injectable Liposomal Bupivacaine in Shoulder Arthroplasty. J Bone Joint Surg Am. 2017. PMID: 28375887. doi:10.2106/JBJS.16.00296
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。